
Ricky Sun, Bain Capital Life Sciences partner
Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan
The Mitsubishi Chemical Group is selling its centuries-old pharmaceutical business to Bain Capital in a carve-out worth about $3.3 billion.
The deal comes after Japan …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.